| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2011NatCo...2..338K |
| P356 | DOI | 10.1038/NCOMMS1345 |
| P698 | PubMed publication ID | 21654638 |
| P50 | author | Kazuhiko Koike | Q21699620 |
| Motoyuki Otsuka | Q61157106 | ||
| P2093 | author name string | Masao Omata | |
| Naoya Kato | |||
| Weiping J Zhang | |||
| Haruhiko Yoshida | |||
| Yuji Kondo | |||
| Takeshi Yoshikawa | |||
| Charles Vadnais | |||
| Akemi Takata | |||
| Takahiro Kishikawa | |||
| Masao Akanuma | |||
| Zhifang Xie | |||
| Alain Nepveu | |||
| Kentaro Kojima | |||
| Young Jun Kang | |||
| P2860 | cites work | Downregulation of miR-122 in the rodent and human hepatocellular carcinomas | Q24631076 |
| A mammalian microRNA expression atlas based on small RNA library sequencing | Q24644709 | ||
| MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development | Q24648202 | ||
| MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib | Q24655048 | ||
| Integration of microRNA miR-122 in hepatic circadian gene expression | Q24657953 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| The roles of CUX1 homeodomain proteins in the establishment of a transcriptional program required for cell migration and invasion | Q42176518 | ||
| p53 targets chromatin structure alteration to repress alpha-fetoprotein gene expression | Q42660335 | ||
| CUTL1 is phosphorylated by protein kinase A, modulating its effects on cell proliferation and motility | Q42803832 | ||
| Cux-1 transgenic mice develop glomerulosclerosis and interstitial fibrosis | Q44358725 | ||
| Clinical classification of hepatoma in Japan according to serial changes in serum alpha-fetoprotein levels | Q45025831 | ||
| Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types | Q45381635 | ||
| High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. | Q45601546 | ||
| Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA. | Q45802406 | ||
| A novel orthotopic tumor model to study growth factors and oncogenes in hepatocarcinogenesis. | Q46361400 | ||
| Polycystic kidneys caused by sustained expression of Cux1 isoform p75. | Q46690342 | ||
| Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. | Q52107054 | ||
| Clinicopathologic features of poorly differentiated hepatocellular carcinoma | Q79839804 | ||
| Epidemiology of hepatocellular carcinoma in USA | Q81314601 | ||
| Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomas | Q82297408 | ||
| AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC | Q84563819 | ||
| The functions of animal microRNAs | Q27860621 | ||
| The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 | ||
| Silencing of microRNAs in vivo with 'antagomirs' | Q27860891 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Sorafenib in advanced hepatocellular carcinoma | Q27861075 | ||
| Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA | Q27861124 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| Role of microRNAs in plant and animal development | Q28188025 | ||
| Zinc finger protein ZBTB20 is a key repressor of alpha-fetoprotein gene transcription in liver | Q28593430 | ||
| miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting | Q29547487 | ||
| LNA-mediated microRNA silencing in non-human primates | Q29615962 | ||
| RHO-GTPases and cancer | Q29616099 | ||
| Cut homeobox 1 causes chromosomal instability by promoting bipolar division after cytokinesis failure | Q30498092 | ||
| Transgenic mice expressing the p75 CCAAT-displacement protein/Cut homeobox isoform develop a myeloproliferative disease-like myeloid leukemia | Q33372852 | ||
| Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. | Q34138074 | ||
| Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice | Q34372342 | ||
| The p110 isoform of the CDP/Cux transcription factor accelerates entry into S phase | Q34519903 | ||
| MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma | Q34756477 | ||
| MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. | Q34786558 | ||
| MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma | Q34964774 | ||
| Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties | Q34993023 | ||
| Hepatomegaly in transgenic mice expressing the homeobox gene Cux-1 | Q35636935 | ||
| Deregulated expression of the homeobox gene Cux-1 in transgenic mice results in downregulation of p27(kip1) expression during nephrogenesis, glomerular abnormalities, and multiorgan hyperplasia | Q35679923 | ||
| Issues in screening and surveillance for hepatocellular carcinoma | Q35929133 | ||
| Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma | Q36045666 | ||
| Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients | Q36615885 | ||
| The multiple roles of CUX1: insights from mouse models and cell-based assays | Q37099815 | ||
| The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation | Q37286651 | ||
| Molecular therapy for the treatment of hepatocellular carcinoma | Q37329048 | ||
| Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients | Q38207543 | ||
| CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness | Q38325113 | ||
| Ikappa B kinasebeta/nuclear factor-kappaB activation controls the development of liver metastasis by way of interleukin-6 expression | Q39788628 | ||
| p110 CUX1 homeodomain protein stimulates cell migration and invasion in part through a regulatory cascade culminating in the repression of E-cadherin and occludin | Q39820143 | ||
| Genome-wide location analysis and expression studies reveal a role for p110 CUX1 in the activation of DNA replication genes | Q40051898 | ||
| CUTL1 promotes tumor cell migration by decreasing proteasome-mediated Src degradation. | Q40157234 | ||
| A versatile tool for conditional gene expression and knockdown | Q40325913 | ||
| CUX1 and E2F1 regulate coordinated expression of the mitotic complex genes Ect2, MgcRacGAP, and MKLP1 in S phase. | Q41831270 | ||
| P2507 | corrigendum / erratum | Erratum: Corrigendum: MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma | Q61207060 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 338 | |
| P577 | publication date | 2011-06-07 | |
| P1433 | published in | Nature Communications | Q573880 |
| P1476 | title | MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma | |
| P478 | volume | 2 |
| Q90606582 | 5-Hydroxytryptamine Receptor 1D Aggravates Hepatocellular Carcinoma Progression Through FoxO6 in AKT-Dependent and Independent Manners |
| Q38188460 | Antitumor function of microRNA-122 against hepatocellular carcinoma |
| Q42255569 | Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal |
| Q34282931 | Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival |
| Q34971134 | Case report evidence of relationships between hepatocellular carcinoma and ochratoxicosis |
| Q37534945 | Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring |
| Q36011412 | Circulating tumor cells measurements in hepatocellular carcinoma |
| Q55268879 | Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review. |
| Q27026846 | Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma |
| Q35781589 | Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine. |
| Q38334014 | Diagnostic and therapeutic application of noncoding RNAs for hepatocellular carcinoma. |
| Q89641606 | Enlarged selection criteria for hepatocellular cancer: is the upper limit needed? |
| Q61207060 | Erratum: Corrigendum: MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma |
| Q36129129 | Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. |
| Q35595069 | HBx induced AFP receptor expressed to activate PI3K/AKT signal to promote expression of Src in liver cells and hepatoma cells |
| Q38989340 | Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP. |
| Q59136670 | ISGF3 with reduced phosphorylation is associated with constitutive expression of interferon-induced genes in aging cells |
| Q36362912 | Impact of CUX2 on the female mouse liver transcriptome: activation of female-biased genes and repression of male-biased genes |
| Q38890010 | MicroRNA-122 regulates polyploidization in the murine liver. |
| Q35200832 | MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA. |
| Q34294469 | MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression. |
| Q89287914 | MicroRNAs and liver disease |
| Q35715931 | MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine |
| Q30439971 | MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma |
| Q36691039 | Mutual antagonism between hepatitis B viral mRNA and host microRNA let-7. |
| Q41990459 | New Insights into the Epigenetics of Hepatocellular Carcinoma. |
| Q37729138 | Novel insights into the molecular mechanisms of α-fetoprotein expression and malignant phenotypes of hepatocellular carcinoma |
| Q37644875 | Novel miR-122 delivery system based on MS2 virus like particle surface displaying cell-penetrating peptide TAT for hepatocellular carcinoma |
| Q35619104 | Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma |
| Q35044479 | Predicting tissue specific transcription factor binding sites |
| Q28272678 | Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges |
| Q92615766 | Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors |
| Q36002513 | ROCK inhibition enhances microRNA function by promoting deadenylation of targeted mRNAs via increasing PAIP2 expression |
| Q53123123 | Recent topics on α-fetoprotein. |
| Q34026072 | Receptor for activated protein kinase C: requirement for efficient microRNA function and reduced expression in hepatocellular carcinoma. |
| Q39092681 | Regulation of the expression of the liver cancer susceptibility gene MICA by microRNAs. |
| Q42768559 | Repeatable, Inducible Micro-RNA-Based Technology Tightly Controls Liver Transgene Expression. |
| Q48173337 | SERS- and luminescence-active Au-Au-UCNP trimers for attomolar detection of two cancer biomarkers. |
| Q38412315 | Significant biomarkers for the management of hepatocellular carcinoma |
| Q90076663 | Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection |
| Q34298155 | Silencing of microRNA-122 enhances interferon-α signaling in the liver through regulating SOCS3 promoter methylation |
| Q38975168 | Specific delivery of microRNA93 into HBV-replicating hepatocytes downregulates protein expression of liver cancer susceptible gene MICA. |
| Q35631841 | Stem cells in liver diseases and cancer: recent advances on the path to new therapies |
| Q92881310 | TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma |
| Q91788808 | Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: A prospective study |
| Q37943714 | The efficacy of miRNA122, a novel therapeutic target, for predicting the progression of hepatocellular carcinoma (HCC). |
| Q42576894 | The flavonoid apigenin improves glucose tolerance through inhibition of microRNA maturation in miRNA103 transgenic mice. |
| Q38968725 | The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels. |
| Q37747422 | The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma. |
| Q38213933 | The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment. |
| Q38164571 | The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects. |
| Q55217703 | Translating epithelial mesenchymal transition markers into the clinic: Novel insights from proteomics. |
| Q34038257 | Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model |
| Q34983857 | Unique haploinsufficient role of the microRNA-processing molecule Dicer1 in a murine colitis-associated tumorigenesis model. |
| Q50561949 | Upregulation of MiR-122 via Trichostatin A Treatments in Hepatocyte-like Cells Derived from Mesenchymal Stem Cells. |
| Q92203798 | Variance component analysis of circulating miR-122 in serum from healthy human volunteers |
| Q36288638 | ZBTB20 is a sequence-specific transcriptional repressor of alpha-fetoprotein gene |
| Q55052792 | ZBTB20 regulates EGFR expression and hepatocyte proliferation in mouse liver regeneration. |
| Q61207060 | Erratum: Corrigendum: MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma | main subject | P921 |
Search more.